Martin Treder

Martin Treder

Grundare på
LTZ Therapeutics, Inc.
Health Technology
Consumer Services
Commercial Services

Profil

Martin Treder was the founder of U3 Pharma AG, founded in 2001, serving as Research Director in 2002.
Dr. Treder was the founder of CT Atlantic Ltd., founded in 2008, serving as Chief Scientific Officer from 2008 to 2014.
Dr. Treder is the founder of LTZ Therapeutics, Inc., founded in 2021, serving as Chief Scientific Officer since 2021.
Dr. Treder is the founder of Shenzhen LTZ Therapeutics Co., Ltd., founded in 2022.
Dr. Treder was Chief Scientific Officer at Affimed NV from 2015 to 2019.
Dr. Treder completed undergraduate studies at Monash University and earned a doctorate from Technische Universität München.

Aktiva positioner av Martin Treder

FöretagPositionStart
Grundare 2021-01-01

Tidigare kända positioner av Martin Treder

FöretagPositionSlut
AFFIMED N.V. Teknisk/Vetenskaplig/F&U Direktör 2019-05-22
Grundare 2014-12-01
Grundare 2008-10-01
Grundare -
Se detaljerna i Martin Treders erfarenhet

Martin Treders utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

20

Första gradens relationer

7

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag7

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Martin Treder